These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8128436)
1. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Triplett DA; Barna LK; Unger GA Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection]. Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068 [TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
4. The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants. Triplett DA; Stocker KF; Unger GA; Barna LK Thromb Haemost; 1993 Dec; 70(6):925-31. PubMed ID: 8165613 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants]. Magdelaine A; Verdy E Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of recently described tests for detection of the lupus anticoagulant. Forastiero RR; Cerrato GS; Carreras LO Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080 [TBL] [Abstract][Full Text] [Related]
7. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests. Zhang L; Whitis JG; Embry MB; Hollensead SC Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739 [TBL] [Abstract][Full Text] [Related]
9. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants. Alving BM; Barr CF; Johansen LE; Tang DB Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants. Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317 [TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Arnout J; Meijer P; Vermylen J Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770 [TBL] [Abstract][Full Text] [Related]
12. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls. Triplett DA J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Rauch J; Tannenbaum M; Neville C; Fortin PR Thromb Haemost; 1998 Dec; 80(6):936-41. PubMed ID: 9869164 [TBL] [Abstract][Full Text] [Related]
14. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism. Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313 [TBL] [Abstract][Full Text] [Related]
15. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients. Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638 [TBL] [Abstract][Full Text] [Related]
16. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies. Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579 [TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Tripodi A; Chantarangkul V; Clerici M; Mannucci PM Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227 [TBL] [Abstract][Full Text] [Related]
19. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107 [TBL] [Abstract][Full Text] [Related]
20. The laboratory heterogeneity of lupus anticoagulants. Triplett DA; Brandt JT; Maas RL Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]